Are you initiating/discussing peanut OIT in most children less than age 2 due to the benefits of desensitization and remission?  

The relative risks and benefits must be weighed as an alternative to omalizumab or in combination with omalizumab. Between 25-40% of patients who are allergic to peanuts are also allergic to at least one tree nut. Although omalizumab has the advantage of providing protection for multiple food allerg...